NCT00514761View on ClinicalTrials.gov

Phase II Efficacy Study of AZD6244 in Colorectal Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

July 31, 2008

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG

AZD6244

oral vial

DRUG

Capecitabine

oral tablet

Trial Locations (3)

Unknown

Research Site, Goiânia

Research Site, Rio de Janeiro

Research Site, São Paulo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY